Knowledge · Natural Compounds

Turmeric and Curcumin

Turmeric is the ground rhizome of Curcuma longa, curcumin its yellow colouring; human studies show improvements in metabolism, inflammation and joints.

Last updated:

We evaluated 375 human studies on Turmeric and Curcumin, including 242 randomised controlled trials and 101 meta-analyses or systematic reviews; the controlled studies include 16,291 participants in total. As of 4 October 2026.

This page as PDF · Summary

1. What Is Turmeric and Curcumin? Occurrence, Origin and Forms

Turmeric is the dried and ground rhizome (rootstock) of Curcuma longa, a plant in the ginger family. Curcumin is the yellow pigment of the rhizome and belongs to the group of curcuminoids. Turmeric is traditionally used as a spice and colouring.

Curcuma longa is cultivated in tropical regions of Asia; the part used is the underground rhizome, where the curcuminoids are located. The plant needs a warm, humid climate and is propagated through the rhizome.

For the spice and for extracts the rhizome is dried and ground; curcumin extracts are made from that powder and adjusted to a defined curcuminoid content. Studies examine, among other forms, the powder, extracts, preparations with additives meant to improve absorption, and individual curcuminoids.

Forms and Preparations Studied

  • Turmeric powder from the ground rhizome
  • Curcuminoid-rich extract
  • Curcumin with piperine from black pepper
  • Curcumin in phytosome form
  • Individual curcuminoids such as demethoxycurcumin and bisdemethoxycurcumin
  • Hydrogenated curcumin (tetrahydrocurcumin)

Not covered on this page:

  • Other Curcuma species such as zedoary (Curcuma zedoaria) and Javanese turmeric (Curcuma xanthorrhiza)
  • Other ginger-family plants such as ginger (Zingiber officinale) and galangal (Alpinia)
  • The essential oil obtained from turmeric, which contains no curcuminoids

2. What Does Turmeric and Curcumin Do? Results by Area

AreaResult in controlled studiesStrength of evidenceStudiesParticipants
Metabolism and blood valuesmostly improvedhigh24 meta-analyses · 90 controlled · 16 other5,919
Inflammation-related conditionsmostly improvedhigh17 meta-analyses · 94 controlled · 22 other6,429
Joints and the musculoskeletal systemmostly improvedhigh16 meta-analyses · 43 controlled · 20 other3,339
Absorption in the bodymostly improvedhigh1 meta-analyses · 28 controlled · 7 other1,077
Digestionmostly improvedhigh4 meta-analyses · 13 controlled · 2 other511
Tolerability and safetymostly no differencehigh2 meta-analyses · 13 controlled · 89 other1,732
Other investigationsmixedhigh22 meta-analyses · 127 controlled · 34 other8,900

How to read the table: counted are human studies whose results concern the area. “High” means at least one meta-analysis and two controlled studies showing improvement, or at least three controlled studies of which three quarters show improvement, with at least 300 participants in total. “Moderate” means at least two controlled studies showing improvement, as a majority, or one meta-analysis alongside controlled studies. “Low” means one controlled study showing improvement. Where an area has no controlled study, the strength of evidence is at most “low” (result “reviews only” or “observational data only”). Everything else is “unclear”. A study counts as showing improvement when at least half of its outcomes in this area improved. Reviews of combination products do not count as meta-analyses; results that only describe side effects or shares of users do not count as an effect. The same study is counted only once.

3. What the Studies Show in Detail

Turmeric and Curcumin, Metabolism and Blood Values: Human Studies

For metabolism and blood values, curcumin showed improvements in fasting blood glucose 4822394387 and HbA1c 8224387106110 in several controlled studies. Insulin resistance also improved in several controlled studies 46970106140316, as did liver enzymes 44467168220 and markers of oxidative stress 39112140174. Curcuminoid-rich extracts, curcumin in phytosome form and partly unspecified preparations were investigated; the robustness is high, as 24 meta-analyses and 90 controlled studies with a total of 5919 participants are available. A randomised controlled study in healthy older people found elevated blood glucose under lipidated curcumin 170. Many studies do not precisely state form, curcuminoid content and duration of administration, and information on manufacturer funding is largely missing.

StudyDesign · participantsPreparation · dose · duration · comparisonResult
2 Wang et al. 2025meta-analysis · 30,133 participantsDietary supplements, including curcumin; vs. Control groups of included randomized trialsFasting glucose: improved (SMD = -3.43)
3 Wan et al. 2024meta-analysis · 17,126 participantsPolyphenol antioxidant supplements, including curcumin; vs. Control groups of the included randomized trialsindicators of glucose metabolism: improved
4 Jafari et al. 2024meta-analysis · 7,216 participantsCurcuma longa L. (form not specified in abstract); vs. PlaceboFasting blood sugar: improved; High-density lipoprotein: improved; Weight: improved
8 Amgain et al. 2025meta-analysis · 3,706 participantsCurcumin (turmeric extract); exact form not reported; vs. Placebo or control (RCTs within reviews)Fasting blood glucose: improved (MD = - 6.30 mg/dL; 95% CI: - 9.33, - 3.27); HbA1c: improved (MD = - 0.31%; 95% CI: - 0.57, - 0.05); LDL cholesterol: improved (MD = - 5.95 mg/dL; 95% CI: - 9.43, - 2.47)
13 Ranneh et al. 2024systematic review · 1,840 participantsDietary polyphenol supplementation, including turmeric and curcumin; vs. Control groups of the included RCTsliver enzymes: improved; lipid profile: improved; insulin resistance: improved
19 Xie et al. 2026meta-analysis · 1,502 participantsDietary polyphenols, including curcuminoids, flavonoids, stilbenes; Recommendation: long-term over 8 weeks; vs. Polyphenol supplementation versus controlSerum uric acid: no difference (non-significant effects); Serum uric acid (flavonoids/anthocyanins): improved (significantly reduced SUA levels)
22 Mokgalaboni et al. 2024meta-analysis · 1,382 participantsCurcumin supplementation (form not specified); vs. PlaceboFasting blood glucose: improved (MD = -11.48 mg/dL, 95%CI (-14.26, -8.70), p < 0.01); Glycated hemoglobin: improved (MD = -0.54%, 95%CI (-0.73, -0.35), p < 0.01)
23 Bahari et al. 2026systematic review · 1,303 participantsCurcumin/turmeric supplementation; vs. Placebo or controlSerum creatinine: no difference (WMD: -0.01 mg/dL, 95% CI: -0.03 to 0.01, p = 0.519); Blood urea nitrogen (BUN): no difference (WMD: -0.41 mg/dL, 95% CI: -3.15 to 2.33, p = 0.769); Uric acid: unclear (WMD: -1.46 mg/dL, 95% CI: -2.93 to 0.02, p = 0.053)

Further studies in this area: 32 34 39 40 42 43 44 45 47 58 59 60 64 65 67 68 69 70 71 73 74 75 76 81 86 87 92 98 106 110 111 112 118 125 134 135 137 138 139 140 143 145 146 147 148 151 157 161 162 164 165 168 169 170 172 173 174 176 177 178 179 180 181 183 187 189 191 192 194 197 199 200 205 208 209 214 216 219 220 221 222 224 226 235 239 240 243 244 245 246 247 252 254 256 258 262 264 265 270 273 276 277 281 284 285 291 294 307 308 309 316 322 324 326 327 331 338 345 364 366 368 369

Turmeric and Curcumin and Inflammation-Related Conditions: Human Studies

In inflammation-related complaints, curcumin showed improvements in C-reactive protein in several controlled studies and meta-analyses 4515223953. Tumor necrosis factor-alpha, a messenger substance of inflammation, also decreased more strongly than under control in several studies 51539111112159. Likewise, the erythrocyte sedimentation rate 5372119190198279 and the inflammatory messengers interleukin-6 5111112159174 and interleukin-1 beta 111112174 improved. As an adjunct to periodontal treatment, curcumin lowered the gingival index more strongly than the treatment alone 35250; in rheumatoid arthritis, the rheumatoid factor decreased more strongly than under control 72279. A meta-analysis on knee osteoarthritis found no difference from placebo for erythrocyte sedimentation rate and interleukin-6 15. Two further controlled studies also saw no difference in the inflammatory markers 247323. Curcumin, curcuminoid-rich extracts, turmeric powder, curcumin with piperine, and phytosome forms were investigated. Findings from a meta-analysis of various polyphenols in rheumatoid arthritis cannot be attributed to curcumin alone 7. The findings come predominantly from small to medium-sized studies of varying form, dose, and duration, which limits the informative value.

StudyDesign · participantsPreparation · dose · duration · comparisonResult
4 Jafari et al. 2024meta-analysis · 7,216 participantsCurcuma longa L. (form not specified in abstract); vs. PlaceboC-reactive protein: improved; Glutathione: improved; Superoxide dismutase: improved
5 Naghsh et al. 2023meta-analysis · 5,870 participantsCurcumin supplementation; vs. Placebo or controlC-reactive protein (CRP): improved (ES = -0.74; 95% CI: -1.11, -0.37, p < 0.001); Interleukin-6 (IL-6): improved (ES = -1.07; 95% CI: -1.71, -0.44, p < 0.001); Tumour necrosis factor α (TNF-α): improved (ES: -1.92, 95% CI: -2.64, -1.19, p < 0.0)
7 Long et al. 2023meta-analysis · 3,852 participantsCurcumin among 14 other polyphenols (mixture); vs. Placebo or control, pooled across 47 RCTsC-reactive protein (CRP) and erythrocyte sedimentation rate (ESR): improved; Oxidative stress levels: improved
11 Zeng et al. 2022meta-analysis · 2,396 participantsCurcumin and Curcuma longa extract; 120 mg to 1500 mg; 4 to 36 weeks; vs. randomized controlled trials (control groups not specified)inflammation severity: improved
13 Ranneh et al. 2024systematic review · 1,840 participantsDietary polyphenol supplementation, including turmeric and curcumin; vs. Control groups of the included RCTsinflammatory cytokines: improved
15 Hsueh et al. 2025meta-analysis · 1,705 participantsCurcumin (form not specified); vs. Placebo or control groupC-reactive protein (CRP): improved (SMD = -0.906, 95% CI = -1.543 ~ -0.269, P value = 0.005); Tumor necrosis factor-alpha (TNF-alpha): improved (SMD = -0.921, 95% CI = -1.817 ~ -0.026, P value = 0.044); Erythrocyte sedimentation rate (ESR): no difference (SMD = -0.064, 95% CI = -0.064 ~ 0.541, P value = 0.836)
20 Chen et al. 2025meta-analysis · 1,463 participantsDietary supplements including curcumin; vs. Network meta-analysis comparing supplementsInterleukin-22: improved (curcumin reduced IL-22)
22 Mokgalaboni et al. 2024meta-analysis · 1,382 participantsCurcumin supplementation (form not specified); vs. PlaceboC-Reactive Protein: improved (SMD = -0.59, 95%CI (-1.11, -0.07), p = 0.03)

Further studies in this area: 25 31 35 39 47 52 53 54 55 57 59 66 68 70 72 75 76 81 83 102 107 110 111 112 114 117 118 119 123 139 140 141 145 146 147 153 154 156 159 162 164 165 167 171 172 174 176 177 179 180 185 186 187 188 190 191 195 196 198 200 201 204 205 206 208 209 211 213 216 217 218 219 221 224 228 231 240 241 244 247 250 251 254 256 260 261 262 264 266 269 274 279 287 291 293 294 298 304 307 309 313 314 315 316 318 320 323 325 330 331 333 336 340 350 354 355 356 357 361 362 363 364 368 369 370

Turmeric and Curcumin, Joints and the Musculoskeletal System: Human Studies

In joint and movement complaints, curcumin showed improvements in pain intensity in several controlled studies, predominantly in knee osteoarthritis 1124375380101. WOMAC scores 680101206 and KOOS pain scores 123202 also improved more than under placebo. Several controlled studies also found better function scores than in the comparison group 93229309 and, in rheumatoid arthritis, lower disease activity 537291279. After unaccustomed exertion, muscle soreness recovered faster under a turmeric preparation than under placebo, and muscle strength declined less 242. Investigated were predominantly curcuminoid-rich extracts, partly in bioavailability-improved or water-dispersible forms, as well as topical curcumin gel and hydrogenated curcumin 202229279309333. Two controlled studies found no difference from ibuprofen 104 or paracetamol 336, respectively, in pain and function. Disease activity in rheumatoid arthritis and lupus 52, inflammatory markers and synovitis in knee osteoarthritis 323, and performance tests under curcumin gel 202 remained without difference from the control. The findings come partly from combination preparations with Boswellia serrata, NSAIDs or chondroprotective agents and cannot be attributed to curcumin alone 12161718. The evidence is strong, but many studies are small and short, the forms and additives are inconsistent, and information on manufacturer funding is largely missing.

StudyDesign · participantsPreparation · dose · duration · comparisonResult
6 Zhang et al. 2025meta-analysis · 4,599 participantsCurcumin as a nutritional supplement; vs. PlaceboWOMAC function: improved; WOMAC pain, stiffness, VAS pain: unclear
7 Long et al. 2023meta-analysis · 3,852 participantsCurcumin among 14 other polyphenols (mixture); vs. Placebo or control, pooled across 47 RCTsDisease activity score for 28 joints (DAS28): improved
11 Zeng et al. 2022meta-analysis · 2,396 participantsCurcumin and Curcuma longa extract; 120 mg to 1500 mg; 4 to 36 weeks; vs. randomized controlled trials (control groups not specified)pain levels: improved
12 Zhao et al. 2024meta-analysis · 2,175 participantsCurcumin alone or curcumin plus NSAIDs/chondroprotective agents; vs. placebo, NSAIDs, curcumin+NSAIDs, curcumin+chondroprotective agentsVAS pain score: improved (MD = -1.63, 95% CI: -2.91 to -0.45); total WOMAC score: improved (MD = -18.85, 95% CI: -29.53 to -8.76); use of rescue medication: improved (OR = 0.17, 95% CI: 0.08 to 0.36)
14 Del et al. 2017meta-analysis · 1,741 participantsOral herbal medicines, including Curcuma longa; vs. Placebo or controlPain and physical function: no difference
16 Inprasit et al. 2026meta-analysis · 1,633 participantsCurcuma longa (CL), Boswellia serrata (BS), and mixed formulation; vs. Placebo or other intervention groupsPain (VAS): improved (SMD: -2.82; 95 %CI: -5.30 to -0.33); WOMAC pain, stiffness, and knee function: improved
17 Zeng et al. 2021systematic review · 1,621 participantsCurcuma longa extract and curcumin supplements; Recommended: more than 12 weeks; vs. Placebo, NSAIDs, NSAIDs plus curcuminVAS pain: improved; WOMAC pain: improved; WOMAC function: improved
18 Wan et al. 2022systematic review · 1,533 participantsCurcuminoid formulations alone or with conventional therapy; vs. NSAIDs or chondroitin sulfate/glucosamine aloneVAS pain: no difference; total WOMAC score: no difference; WOMAC pain/stiffness/physical function: no difference

Further studies in this area: 24 27 29 30 31 36 37 38 52 53 61 72 76 77 79 80 90 91 93 97 99 100 101 104 108 109 115 116 117 122 123 141 142 143 149 153 154 160 163 171 179 188 201 202 206 219 225 229 232 234 242 245 256 275 279 280 285 287 293 309 323 328 333 336 337 343 347 348 353 370 372

Turmeric and Curcumin and Absorption in the Body: Human Studies

Specially prepared forms improved absorption in several controlled studies: micellar, water-soluble, and newly developed preparations achieved higher systemic exposure than conventional curcumin or standard extract 278294299. The peak plasma concentrations were also higher with these preparations 278294299. Curcumin packaged in fat or water particles (liposomal, nanoemulsified, micellar) was measurable in the blood 233245247. An overview mainly of animal and laboratory studies suggests that curcumin is better absorbed in tiny carrier particles (nanocarriers). The findings apply to the respective form investigated — curcuminoid-rich extracts, phytosome and micellar preparations, and ground turmeric rhizome powder — and not to curcumin in general. No difference was found in free curcuminoids between five preparations, between piperine combination and standard extract 271, or in plasma levels after three doses of turmeric powder 305. Most studies were small and investigated healthy volunteers over a short period; the informative value is therefore limited despite the high number of controlled studies.

StudyDesign · participantsPreparation · dose · duration · comparisonResult
73 Al-Makhmari et al. 2025systematic reviewCurcumin (Curcuma longa), form and dose not reported; vs. other herbs and controls, not detailedbioavailability: unclear (its bioavailability remains a challenge)
79 Sato et al. 2025systematic reviewCurcumin or natural derivatives in nanocarrier systems; vs. Free curcumin versus encapsulated curcuminSolubility, bioavailability and stability: improved
116 Bhat et al. 2023randomised controlled · 200 participantsOral curcumin 1 g with piperine 5 mg; 1 g curcumin plus 5 mg piperine twice daily; 52 weeks; vs. Placebo, concurrent csDMARD taperingCorrelation of serum curcuminoid levels with flares: no difference (adjusted HR = 0.99 (95% CI: 0.97-1.0))
126 Wightman et al. 2023randomised controlled · 128 participantsMulti-ingredient herbal supplement with turmeric whole powder and Turmeric Wholistic™ extract; 90 days (12 weeks); vs. Placebo, randomized, parallel groupstyrosine in urinary metabolome: improved
153 Majumdar et al. 2025randomised controlled · 90 participantsCL20192 capsule: Boswellia serrata and Curcuma longa extracts; 300 mg once daily; 90 days; vs. Placebo capsuleSerum levels of boswellic acids and curcuminoids: improved
158 Panahi et al. 2016randomised controlled · 89 participantsCurcuminoids (1500 mg/day) plus piperine (15 mg/day); 1500 mg curcuminoids + 15 mg piperine daily; 4 weeks; vs. Placebo, double-blind, randomizedSerum GSH levels: improved (p < 0.001); Serum MDA levels: improved (p < 0.001)
162 Azhdari et al. 2026randomised controlled · 84 participantsCurcumin 500 mg/day, alone or with zinc 30 mg/day; Curcumin 500 mg/day; zinc 30 mg/day; 90 days; vs. Placebo, four groups (curcumin, zinc, curcumin+zinc, placebo)serum zinc: improved (p=0.001); urinary zinc: improved (p=0.04)
214 Pandaran et al. 2016randomised controlled · 60 participantsCurQfen (curcumagalactomannoside), natural curcumin with fenugreek fiber; 500 mg twice daily; single dose 500 mg once daily; 30 days; vs. standard curcumin and placebofree curcuminoids bioavailability, single dose: improved (30.7-fold); free curcuminoids bioavailability, repeated dose: improved (39.1-fold)

Further studies in this area: 233 243 245 247 263 271 274 278 290 292 294 296 297 299 300 301 305 311 318 332 342 346 351 354 357 360 362 364

Turmeric and Curcumin and Digestion: Human Studies

In women with severe obesity, curcumin alleviated gastrointestinal complaints such as belching and constipation more strongly than placebo 265; in children with autism, complaints and fecal calprotectin decreased 198. In ulcerative colitis, a meta-analysis and two reviews of small studies found evidence of a benefit of curcumin, especially as an adjunct to standard therapy 919496. A review saw possible effectiveness in irritable bowel syndrome and chronic inflammatory bowel diseases 85. In irritable bowel syndrome, a meta-analysis found a favorable but not confirmed effect 51, a small randomized study found no difference in gastrointestinal symptoms 291. In hepatic steatosis and liver stiffness, curcumin improved the values in a randomized controlled study 174, and in periodontitis, curcuminoid gel or curcumin gel improved the periodontal parameters 269304. The findings are based predominantly on small studies of short duration and without information on manufacturer funding; the forms investigated ranged from curcuminoid-rich extract to curcumin with piperine and phytosome form to combination preparations with other substances. Findings from combination preparations are not due to curcumin alone: an herbal preparation with turmeric lowered Sutterella and constipation 126, curcumin with piperine the NAFLD severity 173, a curcumin-boswellia phytosome bloating and abdominal pain 189.

StudyDesign · participantsPreparation · dose · duration · comparisonResult
51 Ng et al. 2018meta-analysis · 326 participantsCurcumin (preparation not specified); vs. Control group in randomized controlled trialsIBS symptom severity from baseline: no difference (pooled standardized mean difference from baseline IBS severity rating -0.466, 95% CI: -1.113 to 0.182, p = 0.158)
85 Thavorn et al. 2024systematic reviewTurmeric (form and curcuminoid content not reported); vs. Randomized controlled trials and comparative observational studiesEfficacy in IBD or IBS: improved; Efficacy in other digestive disorders: unclear
91 Zeng et al. 2022meta-analysisCurcumin and Curcuma longa extract; vs. Placebo or control in included RCTsClinical or laboratory improvement in ulcerative colitis: improved
94 Coelho et al. 2020systematic reviewCurcumin as complementary therapy; vs. Placebo-controlled RCTsMaintenance of remission in ulcerative colitis: improved; Remission in Crohn's disease: unclear
96 Holleran et al. 2020systematic reviewCurcumin as a herbal medicine; vs. Placebo in double-blind randomised controlled trialsEvidence of efficacy in ulcerative colitis: improved
126 Wightman et al. 2023randomised controlled · 128 participantsMulti-ingredient herbal supplement with turmeric whole powder and Turmeric Wholistic™ extract; 90 days (12 weeks); vs. Placebo, randomized, parallel groupsSutterella in gut microbiome and constipation: improved
173 Mirhafez et al. 2021randomised controlled · 79 participantsCurcumin plus piperine; 500 mg/day curcumin; 2 months; vs. Placebo, both groups received diet and exercise adviceNAFLD severity: improved (p = 0.04)
174 Yaikwawong et al. 2025randomised controlled · 78 participantsCurcumin (bioactive polyphenol from turmeric); 1500 mg/day; 12 months; vs. placebo, randomized, double-blindhepatic steatosis: improved; liver stiffness: improved

Further studies in this area: 189 198 265 269 291 302 304 308 314 341 359

Turmeric and Curcumin, Tolerability and Safety: Human Studies

In this area, 13 controlled studies and 2 meta-analyses with a total of 1732 participants were evaluated for the tolerability of turmeric and curcumin. Several controlled studies and reviews described curcuminoids, curcumin in phytosome form and hydrogenated curcuminoids as well tolerated 8589159228279. Liver and kidney values remained unremarkable under curcumin 110, liver enzymes remained unchanged under micellar curcuminoids 247, and laboratory values as well as vital signs did not differ from placebo 203. Meta-analyses and reviews found no increase in adverse events under curcumin 6505193; in a large randomized study over two years, side effects were rare and mild 103. A meta-analysis on curcumin and Curcuma longa extract in various forms of arthritis found no differences in safety endpoints 11. A meta-analysis on Curcuma longa, also as a mixture with Boswellia serrata, found no differences in adverse events 16. A systematic review on Curcuma longa extract and curcumin, partly as a mixture with NSAIDs, reported no differences in adverse events compared with placebo 17. A systematic review found no differences between curcuminoid formulations and NSAIDs in satisfaction, treatment adherence and rescue medication 18. The findings apply to the forms studied — powder, extract, phytosome form and individual substances — and, because of the mostly short study duration and the heterogeneous preparations, can be transferred to long-term use only to a limited extent.

StudyDesign · participantsPreparation · dose · duration · comparisonResult
6 Zhang et al. 2025meta-analysis · 4,599 participantsCurcumin as a nutritional supplement; vs. PlaceboAdverse events
7 Long et al. 2023meta-analysis · 3,852 participantsCurcumin among 14 other polyphenols (mixture); vs. Placebo or control, pooled across 47 RCTsAdverse events
9 Gutsche et al. 2025systematic review · 2,580 participantsCurcumin as complementary therapy, topical or systemic; vs. Control groups of included RCTsVomiting: worsened
11 Zeng et al. 2022meta-analysis · 2,396 participantsCurcumin and Curcuma longa extract; 120 mg to 1500 mg; 4 to 36 weeks; vs. randomized controlled trials (control groups not specified)safety
12 Zhao et al. 2024meta-analysis · 2,175 participantsCurcumin alone or curcumin plus NSAIDs/chondroprotective agents; vs. placebo, NSAIDs, curcumin+NSAIDs, curcumin+chondroprotective agentsincidence of adverse reactions (OR = 0.51, 95% CI: 0.25 to 0.94)
16 Inprasit et al. 2026meta-analysis · 1,633 participantsCurcuma longa (CL), Boswellia serrata (BS), and mixed formulation; vs. Placebo or other intervention groupsAdverse events
17 Zeng et al. 2021systematic review · 1,621 participantsCurcuma longa extract and curcumin supplements; Recommended: more than 12 weeks; vs. Placebo, NSAIDs, NSAIDs plus curcuminAdverse events vs. placebo; Adverse events vs. NSAIDs; Adverse events with curcumin plus NSAIDs
18 Wan et al. 2022systematic review · 1,533 participantsCurcuminoid formulations alone or with conventional therapy; vs. NSAIDs or chondroitin sulfate/glucosamine alonesatisfaction index, global assessment, compliance, rescue medication: no difference

Further studies in this area: 21 24 29 33 38 49 50 51 59 77 78 85 89 90 93 94 99 102 103 104 110 115 116 117 120 122 123 125 129 133 135 142 150 151 152 153 154 159 161 163 175 180 182 185 196 202 203 206 208 209 210 224 225 228 229 232 233 234 236 245 247 248 258 263 268 271 274 275 278 279 282 283 284 285 288 289 290 296 297 301 303 306 309 328 333 336 337 347 348 349 350 351 352 361 362 370

Turmeric and Curcumin: Further Outcomes in Studies

For cognition, several studies found improvements 464957129170, while individual controlled studies showed no difference 49263. For depression 265056112244 and anxiety 2650, several studies also found improvements. The forms ranged from turmeric powder to phytosome; mixed preparations with resveratrol or green tea extract cannot be attributed to curcumin alone 13. The robustness is overall high, but the heterogeneity of the preparations, formulations and endpoints does not allow a uniform statement; it remains open which form and which curcuminoid content are effective for which endpoint.

StudyDesign · participantsPreparation · dose · duration · comparisonResult
1 An et al. 2022meta-analysis · 883,627 participantsCurcumin as micronutrient supplement; vs. Placebo or controlCardiovascular risk factors: improved (moderate- to high-quality evidence for reducing CVD risk factors)
9 Gutsche et al. 2025systematic review · 2,580 participantsCurcumin as complementary therapy, topical or systemic; vs. Control groups of included RCTsOral mucositis: improved; Weight loss: improved; Oral and skin symptoms, pain, body composition, survival, disease progression: unclear
10 Zeng et al. 2025meta-analysis · 2,481 participantsNanocurcumin compared with other nutritional supplements; vs. other supplements, e.g. BSO, probiotics, vitamin DFEV1% (lung function): improved (MD=13, 95% CI (7.7, 18)); FEV1/FVC: improved (MD=12, 95% CI (4.6, 19), p<0.05)
13 Ranneh et al. 2024systematic review · 1,840 participantsDietary polyphenol supplementation, including turmeric and curcumin; vs. Control groups of the included RCTsNAFLD score: improved
18 Wan et al. 2022systematic review · 1,533 participantsCurcuminoid formulations alone or with conventional therapy; vs. NSAIDs or chondroitin sulfate/glucosamine aloneKarnofsky Performance Scale score vs. chondroitin sulfate/glucosamine: no difference
21 Sawangjit et al. 2025meta-analysis · 1,407 participantsTurmeric, mostly nano-curcumin, as adjunct to standard care; Nano-curcumin 160-240 mg/day; vs. Placebo or standard careAll-cause mortality: improved (RR = 0.39; 95 % CI: 0.23-0.67); Need for intubation/mechanical ventilation: improved (RR = 0.35; 95 % CI: 0.17-0.72); Clinical deterioration: improved (RR=0.36; 95 % CI: 0.22-0.59)
25 Indriyani et al. 2025systematic review · 1,244 participantsCurcumin, various formulations; vs. randomized controlled trials (control not specified)antioxidant, collagenase-inhibiting, antifungal and wound-healing properties: improved
26 Yuan et al. 2025systematic review · 1,123 participantsCurcumin from Curcuma longa, various formulations; varied, not reported in abstract; vs. placebo or controlDepressive symptoms (SMD): improved (SMD: -0.65, P = 0.01, 95% CI: -1.16 to -0.13); Anxiety symptoms (SMD): improved (SMD: -0.22, P = 0.01, 95% CI: -0.40 to -0.05)

Further studies in this area: 28 32 41 44 45 46 47 48 49 50 54 56 57 59 62 63 66 70 75 76 78 81 82 83 84 88 89 91 95 102 103 105 107 112 113 114 120 121 122 124 126 127 128 129 130 131 132 133 136 142 143 144 149 150 151 152 153 155 158 159 164 165 166 168 170 175 176 179 181 182 184 185 187 189 190 191 193 196 198 199 200 201 205 207 208 209 210 212 213 214 215 216 219 220 221 223 224 227 228 229 230 237 238 239 240 241 244 246 248 249 251 253 254 255 256 257 259 261 263 267 268 272 273 274 280 281 282 283 284 285 286 287 288 289 293 295 303 305 306 307 310 312 313 314 317 318 319 321 322 325 327 329 334 335 339 344 347 348 349 350 351 353 354 355 356 357 358 360 361 362 363 365 367 371 373

4. How Is Turmeric and Curcumin Dosed? Preparation, Dose and Duration in Studies

The studies used ground turmeric rhizome powder, curcuminoid-rich extracts, curcumin with piperine from black pepper, curcumin in phytosome form as well as individual curcuminoids and hydrogenated curcumin. Some of the investigations tested mixed preparations with other polyphenols, Boswellia serrata or NSAIDs, whose findings cannot be attributed to curcumin alone. Form, curcuminoid content and duration of administration were not precisely stated in many studies.

Preparation or formDoseDurationStudy
oral curcumin (turmeric extract, exact composition not stated)2000 mg per dose, 8 doses over 4 days4 days perioperative102
Oral submicron-powdered curcumin (Theracurmin®)180 mg twice daily2 years103
Curcuma domestica extract (1,500 mg/day)1,500 mg/day4 weeks104
commercially available curcumin 500 mg orally500 mg curcumin daily90 days treatment, then 3 months post-treatment follow-up105
Curcumin extract (Curcuma longa)1500 mg/day12 months106
SinaCurcumin™ nano-curcumin240 mg daily3 days pre-op plus 4 post-op days107
turmeric-Boswellia extract (TBE), 1,000 mg1,000 mg TBE6 hours108
TBF (Rhuleave-K): turmeric and boswellia extracts in sesame oilsingle dose of 1000 mg TBFsingle dose, follow-up up to 6 hours109
Curcumin 1500 mg daily1500 mg/day12 months110
Curcumin (from turmeric root)—12 months111
Curcumin supplement—12 months112
PMSoff supplement containing turmeric among 11 ingredients—2 months113
BV-4051, Ayurvedic polyherbal tablet with Ashwagandha, Boswellia, Ginger and Turmeric—14 days114
CuraMed (curcuminoid extract with turmeric oil) or Curamin (plus boswellic acid)500 mg capsule three times daily (333 mg curcuminoids; 350 mg curcuminoids + 150 mg boswellic acid)12 weeks115
Oral curcumin 1 g with piperine 5 mg1 g curcumin plus 5 mg piperine twice daily52 weeks116

5. Is Turmeric and Curcumin Safe? Side Effects in Studies

Curcumin was well tolerated in most studies 5089159228. Under a Curcuma domestica extract, abdominal pain occurred less often than under ibuprofen 104, other studies reported more gastrointestinal complaints under curcumin 949263275. As an infusion, liposomal curcumin temporarily changed the shape of red blood cells at higher doses 233.

StudyReported side effects
6 Zhang et al. 2025No increase in adverse events versus placebo
7 Long et al. 2023Adding polyphenols did not increase adverse events
9 Gutsche et al. 2025One study reported significantly more vomiting in the curcumin group
11 Zeng et al. 2022Safe in all studies; no further details
12 Zhao et al. 2024curcumin and curcumin+NSAIDs reduced adverse reactions versus NSAIDs
14 Del et al. 2017Adverse events as secondary outcome, no numbers reported
16 Inprasit et al. 2026No significant differences in adverse events across all comparisons
17 Zeng et al. 2021Comparable to placebo; lower than NSAIDs; adding to NSAIDs did not increase events
18 Wan et al. 2022Curcuminoid formulations could alleviate some adverse events caused by NSAIDs
20 Chen et al. 2025Adverse events comparable (RR 1.02, 95% CI 0.94–1.10)
21 Sawangjit et al. 2025Mostly mild gastrointestinal symptoms, comparable to placebo
24 Hsiao et al. 2021Higher AE rates with NSAIDs, significant in only one study

6. What Remains Open: Limits of the Evidence

  • Many studies are small and short, and form, curcuminoid content as well as duration of administration are often not precisely stated.
  • Information on manufacturer funding is largely missing, which makes it difficult to assess the findings.
  • The bioavailability of conventional curcumin is low; the absorption findings apply only to the specific form investigated in each case.
  • Findings from mixed preparations with other polyphenols, Boswellia serrata or NSAIDs cannot be attributed to curcumin alone.
  • It remains open which form and which curcuminoid content are effective for which endpoint.

7. Bottom Line: What Is Established About Turmeric and Curcumin

Turmeric and curcumin have been investigated in numerous controlled human studies and meta-analyses. Improvements are seen in metabolic and blood values, in inflammation-related complaints, in joint and movement complaints as well as in digestive complaints. Specially prepared forms such as micellar and water-soluble preparations increased the absorption of curcuminoids compared with conventional curcumin in small studies. Tolerability was good in most studies, although gastrointestinal side effects occurred more frequently in individual studies.

The validity is limited by the fact that many studies are small and short, form and curcuminoid content remain inconsistent and information on manufacturer funding is largely missing. Individual endpoints remained without difference, and a randomised controlled study in healthy older people found elevated blood glucose under curcumin. Findings from mixed preparations cannot be attributed to curcumin alone.

Frequently Asked Questions

How well has Turmeric and Curcumin been studied in humans?

We evaluated 375 human studies on Turmeric and Curcumin, including 242 randomised controlled trials and 101 meta-analyses or systematic reviews; the controlled studies include 16,291 participants in total. As of 4 October 2026.

Does Turmeric and Curcumin help with metabolism and blood values? What the studies show

We evaluated 24 meta-analyses or systematic reviews, 90 controlled studies and 16 further studies; the controlled studies include 5,919 participants in total. Result of the controlled studies: mostly improved. Strength of evidence under our published rules: high. Sources: 2348

Does Turmeric and Curcumin help with inflammation-related conditions? What the studies show

We evaluated 17 meta-analyses or systematic reviews, 94 controlled studies and 22 further studies; the controlled studies include 6,429 participants in total. Result of the controlled studies: mostly improved. Strength of evidence under our published rules: high. Sources: 45711

Does Turmeric and Curcumin help with joints and the musculoskeletal system? What the studies show

We evaluated 16 meta-analyses or systematic reviews, 43 controlled studies and 20 further studies; the controlled studies include 3,339 participants in total. Result of the controlled studies: mostly improved. Strength of evidence under our published rules: high. Sources: 671112

Does Turmeric and Curcumin help with absorption in the body? What the studies show

We evaluated one meta-analysis or systematic review, 28 controlled studies and 7 further studies; the controlled studies include 1,077 participants in total. Result of the controlled studies: mostly improved. Strength of evidence under our published rules: high. Sources: 7379116126

Does Turmeric and Curcumin help with digestion? What the studies show

We evaluated 4 meta-analyses or systematic reviews, 13 controlled studies and 2 further studies; the controlled studies include 511 participants in total. Result of the controlled studies: mostly improved. Strength of evidence under our published rules: high. Sources: 51859194

Does Turmeric and Curcumin help with tolerability and safety? What the studies show

We evaluated 2 meta-analyses or systematic reviews, 13 controlled studies and 89 further studies; the controlled studies include 1,732 participants in total. Result of the controlled studies: mostly no difference. Strength of evidence under our published rules: high. Sources: 67911

What is the difference between turmeric and curcumin?

Turmeric is the dried and ground rhizome of Curcuma longa, a plant from the ginger family. Curcumin is the yellow colouring of the rhizome and belongs to the group of curcuminoids. Turmeric traditionally serves as a spice and colouring agent.

Which forms of curcumin were investigated in the studies?

Ground turmeric rhizome powder, curcuminoid-rich extracts, curcumin with piperine from black pepper, curcumin in phytosome form as well as individual curcuminoids and hydrogenated curcumin were investigated. Some of the studies tested mixed preparations with other substances. The absorption findings apply only to the specific form investigated in each case.

How well is curcumin tolerated?

Several controlled studies and reviews described curcuminoids, curcumin in phytosome form and hydrogenated curcuminoids as well tolerated 8589159228279. Liver and kidney values remained unremarkable 110, the liver enzymes also under micellar curcuminoids 247. For gastrointestinal side effects, the picture was mixed, and due to the mostly short study duration, the findings can only be transferred to long-term use to a limited extent.

Why is the bioavailability of curcumin an issue?

Conventional curcumin is poorly absorbed; micellar and water-soluble preparations achieved significantly higher blood levels in small studies 278294299. These findings apply only to the specific form investigated in each case. Most of these studies were small and investigated healthy volunteers over a short period.

Can findings from mixed preparations be transferred to curcumin alone?

No. To make a statement about curcumin alone, studies with the individual substance are necessary.

Sources

  1. 1
    An P, Wan S, Luo Y, Luo J, Zhang X, Zhou S et al. · 2022
  2. 2
  3. 3
  4. 4
    Jafari A, Abbastabar M, Alaghi A, Heshmati J, Crowe FL, Sepidarkish M · 2024
  5. 5
    Naghsh N, Musazadeh V, Nikpayam O, Kavyani Z, Moridpour AH, Golandam F et al. · 2023
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
    Del Grossi Moura M, Lopes LC, Biavatti MW, Kennedy SA, de Oliveira E Silva MC, Silva MT et al. · 2017
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20
  21. 21
    Sawangjit R, Sadoyu S, Manosanthipaibul S, Teerawattanapong N, Puttarak P, Wanaratna K et al. · 2025
  22. 22
  23. 23
  24. 24
  25. 25
  26. 26
  27. 27
    Gaffey A, Slater H, Porritt K, Campbell JM · 2017
  28. 28
  29. 29
  30. 30
    Kheiridoost-Langaroodi H, Shakouri SK, Amirpour M, Iranshahi AM, Farshbaf-Khalili A · 2022
  31. 31
  32. 32
  33. 33
    Mirzaei Dahka S, Afsharfar M, Tajaddod S, Sohouli MH, Shekari S, Bakhshi Nafouti F et al. · 2023
  34. 34
  35. 35
  36. 36
  37. 37
  38. 38
  39. 39
  40. 40
  41. 41
    Santana DS, Porto BC, Cardoso RB, Lopes GMM, Gimenez LGS, Passerotti CC et al. · 2026
  42. 42
  43. 43
  44. 44
  45. 45
  46. 46
  47. 47
  48. 48
    Marsh A, Quelch D, Mackonochie M, Hejmadi M, Rolfe V · 2024
  49. 49
  50. 50
    Ng QX, Koh SSH, Chan HW, Ho CYX · 2017
  51. 51
    Ng QX, Soh AYS, Loke W, Venkatanarayanan N, Lim DY, Yeo WS · 2018
  52. 52
  53. 53
  54. 54
  55. 55
  56. 56
    Musazadeh V, Faghfouri AH, Falahatzadeh M, Mahmoudinezhad M, Alizadeh M, Shidfar F · 2026
  57. 57
  58. 58
  59. 59
  60. 60
    Mahapatro A, Jeanty H, Adla Jala SR, Priya Somu K, Madineni G, Mohanty E et al. · 2026
  61. 61
  62. 62
  63. 63
  64. 64
    Andrés CMC, Lastra JMP, Bustamante Munguira E, Juan CA, Lebeña EP · 2026
  65. 65
  66. 66
  67. 67
  68. 68
  69. 69
  70. 70
    Rajabinasab F, Tabatabaei FSA, Kheirandish A, Hajimirzaei P, Abolfazli S, Aromolaran AS et al. · 2025
  71. 71
  72. 72
  73. 73
    Al-Makhmari S, Al-Aufi A, Al-Kindi S, Alriyami M, Sakr H, Boulassel MR et al. · 2025
  74. 74
  75. 75
  76. 76
    Cherappurath N, Navaf M, Ceylan Hİ, Elayaraja M, Sunooj KV, Satheesan ST et al. · 2025
  77. 77
  78. 78
    Parvizi MM, Arefkia A, Dehghan Y, Salimi MA, Fazelzadeh Haghighi N · 2025
  79. 79
    Sato BYS, Chong SI, Souza NMP, Lazo REL, Pontarolo R, Rego FGM et al. · 2025
  80. 80
    Bideshki MV, Jourabchi-Ghadim N, Radkhah N, Behzadi M, Asemani S, Jamilian P et al. · 2024
  81. 81
  82. 82
    Conti V, Polcaro G, De Bellis E, Donnarumma D, De Rosa F, Stefanelli B et al. · 2024
  83. 83
  84. 84
  85. 85
    Thavorn K, Wolfe D, Faust L, Shorr R, Akkawi M, Isaranuwatchai W et al. · 2024
  86. 86
  87. 87
  88. 88
  89. 89
  90. 90
    Safety and Efficacy of Turmeric (Curcuma longa) Extract and Curcumin Supplements in Musculoskeletal Health: A Systematic Review and Meta-Analysis
    Doyle L, Desomayanandam P, Bhuvanendran A, Thanawala S, Shah R, Somepalli V et al. · 2023
  91. 91
  92. 92
    Saeedi F, Farkhondeh T, Roshanravan B, Amirabadizadeh A, Ashrafizadeh M, Samarghandian S · 2022
  93. 93
  94. 94
  95. 95
  96. 96
  97. 97
    Letarouilly JG, Sanchez P, Nguyen Y, Sigaux J, Czernichow S, Flipo RM et al. · 2020
  98. 98
  99. 99
  100. 100
    Liu X, Eyles J, McLachlan AJ, Mobasheri A · 2018
  101. 101
  102. 102
    Garg AX, Devereaux PJ, Hill A, Sood M, Aggarwal B, Dubois L et al. · 2018
  103. 103
  104. 104
    Kuptniratsaikul V, Dajpratham P, Taechaarpornkul W, Buntragulpoontawee M, Lukkanapichonchut P, Chootip C et al. · 2014
  105. 105
  106. 106
  107. 107
  108. 108
  109. 109
  110. 110
  111. 111
  112. 112
    Yaikwawong M, Jansarikit L, Jirawatnotai S, Chuengsamarn S · 2024
  113. 113
  114. 114
  115. 115
  116. 116
  117. 117
  118. 118
  119. 119
  120. 120
  121. 121
  122. 122
  123. 123
  124. 124
  125. 125
  126. 126
  127. 127
  128. 128
    Nikpour F, Ansari S, Abedi P, Jahanfar S, Sharifat N, Hooshmand G et al. · 2024
  129. 129
  130. 130
  131. 131
  132. 132
    Purbadi S, Rustamadji P, Prijanti AR, Sekarutami SM, Sutrisna B, Suyatna FD et al. · 2020
  133. 133
  134. 134
  135. 135
  136. 136
  137. 137
    Panahi Y, Khalili N, Sahebi E, Namazi S, Karimian MS, Majeed M et al. · 2017
  138. 138
    Panahi Y, Khalili N, Sahebi E, Namazi S, Reiner Ž, Majeed M et al. · 2017
  139. 139
  140. 140
  141. 141
  142. 142
  143. 143
  144. 144
    Alirezaei L, Golmohammadi H, Pourrashid MH, Kheiri AA, Sarbakhsh P, Samankan S et al. · 2025
  145. 145
  146. 146
  147. 147
    Panahi Y, Khalili N, Sahebi E, Namazi S, Atkin SL, Majeed M et al. · 2017
  148. 148
  149. 149
  150. 150
  151. 151
  152. 152
  153. 153
  154. 154
  155. 155
  156. 156
  157. 157
  158. 158
  159. 159
  160. 160
  161. 161
  162. 162
  163. 163
  164. 164
  165. 165
  166. 166
  167. 167
  168. 168
  169. 169
  170. 170
  171. 171
  172. 172
  173. 173
  174. 174
  175. 175
  176. 176
  177. 177
    Talebpour A, Mohammadifard M, Zare Feyzabadi R, Mahmoudzadeh S, Rezapour H, Saharkhiz M et al. · 2023
  178. 178
  179. 179
  180. 180
  181. 181
  182. 182
  183. 183
  184. 184
  185. 185
    Somprajob C, Auychai P, Chavanavesh J, Suttamanatwong S · 2025
  186. 186
  187. 187
    Panahi Y, Valizadegan G, Ahamdi N, Ganjali S, Majeed M, Sahebkar A · 2019
  188. 188
    Calderón-Pérez L, Llauradó E, Companys J, Pla-Pagà L, Boqué N, Puiggrós F et al. · 2021
  189. 189
  190. 190
  191. 191
  192. 192
  193. 193
  194. 194
  195. 195
  196. 196
  197. 197
  198. 198
  199. 199
  200. 200
  201. 201
  202. 202
  203. 203
  204. 204
  205. 205
  206. 206
  207. 207
  208. 208
  209. 209
  210. 210
  211. 211
  212. 212
  213. 213
  214. 214
  215. 215
    da Paz Martins AS, de Araújo ORP, da Silva Gomes A, Araujo FLC, Júnior JO, de Vasconcelos JKG et al. · 2025
  216. 216
  217. 217
  218. 218
  219. 219
  220. 220
    Gerami H, Mozaffari-Khosravi H, Mansour A, Sohrabpour AA, Poustchi H, Hashemi Taheri AP et al. · 2025
  221. 221
    Saberi-Karimian M, Keshvari M, Ghayour-Mobarhan M, Salehizadeh L, Rahmani S, Behnam B et al. · 2020
  222. 222
  223. 223
    Rooprai HK, Lawrence P, Ashkan K, Beaney R, Pilkington GJ, Gullan RW · 2026
  224. 224
  225. 225
  226. 226
  227. 227
  228. 228
    Gonzalez-Pons M, Dominguez RL, Montalvan-Sanchez EE, Foster NR, Strand CA, Hernandez-Marrero J et al. · 2026
  229. 229
  230. 230
    Hellou E, Mohsin J, Elemy A, Hakim F, Mustafa-Hellou M, Hamoud S · 2022
  231. 231
  232. 232
  233. 233
    Storka A, Vcelar B, Klickovic U, Gouya G, Weisshaar S, Aschauer S et al. · 2015
  234. 234
  235. 235
  236. 236
    Safety of NR-INF-02, an Extract of Curcuma Longa Containing Turmerosaccharides, in Healthy Volunteers: A Randomized, Open-label Clinical Trial
    Selvi M, Mohan Mv R, Bethapudi B, Mundkinajeddu D, Kumari S · 2022
  237. 237
    Pecoraro L, Zoller T, Atkinson RL, Nisi F, Antoniazzi F, Cavarzere P et al. · 2022
  238. 238
  239. 239
  240. 240
  241. 241
  242. 242
  243. 243
    Gómez-Téllez A, Sierra-Puente D, Muñoz-Gómez R, Ibarra-Pitts A, Guevara-Cruz M, Hernández-Ortega M et al. · 2020
  244. 244
  245. 245
  246. 246
  247. 247
  248. 248
  249. 249
  250. 250
  251. 251
    Kapil D, Bari A, Sharma N, Velpandian T, Sinha R, Maharana P et al. · 2025
  252. 252
  253. 253
  254. 254
  255. 255
  256. 256
    Murillo Ortiz BO, Fuentes Preciado AR, Ramírez Emiliano J, Martínez Garza S, Ramos Rodríguez E, de Alba Macías LA · 2019
  257. 257
    The effects of curcumin on the prevention of atrial and ventricular arrhythmias and heart failure in patients with unstable angina: A randomized clinical trial
    Dastani M, Bigdelu L, Hoseinzadeh M, Rahimi HR, Karimani A, Hooshang Mohammadpour A et al. · 2019
  258. 258
  259. 259
  260. 260
  261. 261
  262. 262
  263. 263
  264. 264
  265. 265
  266. 266
  267. 267
  268. 268
  269. 269
  270. 270
    Saberi-Karimian M, Orooji A, Taghizadeh N, Ekhteraee Toosi MS, Ferns GA, Aghasizadeh M et al. · 2023
  271. 271
    Fança-Berthon P, Tenon M, Bouter-Banon SL, Manfré A, Maudet C, Dion A et al. · 2021
  272. 272
  273. 273
    Effects of a Cinnamon, Curcumin/Turmeric Dietary Supplement on Glucose, Lipid, and Cognitive Measures
    Young H, Clayton D, Masis N, Gaylor C, Benton D · 2020
  274. 274
  275. 275
    Tuntiyatorn P, Lerspongpaibool C, Kanchanathepsak T, Watcharananan I, Tawonsawatruk T · 2025
  276. 276
    Santosa D, Rizqi DM, Pangarsa EA, Setiawan B, Suyono S, Tobing ML et al. · 2025
  277. 277
  278. 278
  279. 279
  280. 280
  281. 281
  282. 282
  283. 283
  284. 284
  285. 285
  286. 286
  287. 287
  288. 288
  289. 289
  290. 290
  291. 291
    van den Belt M, JanssenDuijghuijsen L, Tomassen M, de Roos N, Witteman B, Fança-Berthon P et al. · 2026
  292. 292
    Comparative Pharmacokinetics of Curcuminoids from Water-Dispersible Turmeric Extract Against a Curcuminoids-Piperine Combination: An Open-Label, Randomized, Balanced, 2-Treatment, 2-Sequence, 2-Period Crossover Study
    Thanawala S, Shah R, Doyle L, Upadhyay V · 2024
  293. 293
    Miranda-Castro S, Aidar FJ, de Moura SS, Marcucci-Barbosa L, Lobo LF, de Assis Dias Martins-Júnior F et al. · 2022
  294. 294
  295. 295
  296. 296
  297. 297
  298. 298
  299. 299
  300. 300
  301. 301
  302. 302
    Alvarenga L, Cardozo L, Schultz J, Modolon F, Rosado A, Mafra D · 2026
  303. 303
  304. 304
  305. 305
  306. 306
  307. 307
  308. 308
  309. 309
  310. 310
  311. 311
  312. 312
  313. 313
  314. 314
  315. 315
  316. 316
  317. 317
  318. 318
  319. 319
  320. 320
  321. 321
    Montalvan-Sanchez EE, Hernandez-Marrero J, Norwood DA, González-Pons M, Dominguez RL, Rodriguez LM et al. · 2024
  322. 322
  323. 323
  324. 324
  325. 325
  326. 326
  327. 327
  328. 328
  329. 329
  330. 330
  331. 331
    Ahmed Nasef N, Thota RN, Mutukumira AN, Rutherfurd-Markwick K, Dickens M, Gopal P et al. · 2022
  332. 332
  333. 333
  334. 334
  335. 335
    Pawar KS, Mastud RN, Pawar SK, Pawar SS, Bhoite RR, Bhoite RR et al. · 2021
  336. 336
    Singhal S, Hasan N, Nirmal K, Chawla R, Chawla S, Kalra BS et al. · 2021
  337. 337
  338. 338
  339. 339
    Manarin G, Anderson D, Silva JME, Coppede JDS, Roxo-Junior P, Pereira AMS et al. · 2019
  340. 340
  341. 341
  342. 342
  343. 343
  344. 344
    Stancioiu F, Mihai D, Papadakis GZ, Tsatsakis A, Spandidos DA, Badiu C · 2019
  345. 345
    Deane CS, Din USU, Sian TS, Smith K, Gates A, Lund JN et al. · 2022
  346. 346
    Sunagawa Y, Hirano S, Katanasaka Y, Miyazaki Y, Funamoto M, Okamura N et al. · 2015
  347. 347
  348. 348
  349. 349
    Bonucci M, Fuggetta MP, Anelli L, Giannarelli D, Fiorentini C, Ravagnan G · 2025
  350. 350
  351. 351
  352. 352
  353. 353
  354. 354
  355. 355
  356. 356
    Wang Q, Jiang K, Lan X, Zhang L, Duan Y, Gao J et al. · 2026
  357. 357
  358. 358
  359. 359
    Caputo C, De Maio AC, Lombardi A, Sperlongano R, Caraglia M, Cautela D · 2026
  360. 360
  361. 361
  362. 362
  363. 363
    Arjona-Ruiz C, Valdez-Morales EE, Guerrero-Alba R · 2026
  364. 364
  365. 365
    Talath S, El-Tanani M, Wali AF, Rabbani SA, Bhongande B, Ibraheem W et al. · 2026
  366. 366
  367. 367
  368. 368
    Phytochemicals from medicinal plants as alternative therapeutics for metabolic syndrome: A review of randomized controlled trials
    Rad MS, Jamialahmadi T, Kesharwani P, Sahebkar A · 2025
  369. 369
  370. 370
  371. 371
    Herbal Medicines in Autism Spectrum Disorder: Therapeutic Potential, Plant Components, and Dosage Guidelines
    Aldekhail NM, Khojah H, Alsaadoun NH, Al-Sanea MM, Alshammari SB, Alhazeemi AH et al. · 2025
  372. 372
  373. 373
    Gagliardi S, Morasso C, Stivaktakis P, Pandini C, Tinelli V, Tsatsakis A et al. · 2020

Every statement on this page carries its evidence tier — proven, plausible or hypothesis — and leads to the original work. The decision in the individual case rests with the practitioner; we provide the connections.

International Health Research · https://ih-research.com/en/knowledge/turmeric-and-curcumin/ · Last updated: 2026-10-15